Obstructive Sleep Apnoea (OSA) affects an estimated 1.5 million Australians. With long hospital waitlists for in-lab Polysomnography (PSG), Level 4 Home Sleep Apnoea Testing using continuous wearable pulse oximetry provides Australian clinics and GP networks with a reliable, scalable first-line screening pathway.
The Oxygen Desaturation Index (ODI) measures the frequency of arterial oxygen desaturations (≥3% or ≥4%) per hour of sleep:
| ODI (Events/Hour) | Severity Level | Australian Clinical Pathway |
|---|---|---|
| < 5 | Normal | General wellness & lifestyle monitoring |
| 5 – 14.9 | Mild OSA | Positional therapy & weight management |
| 15 – 29.9 | Moderate OSA | CPAP trial / Mandibular Advancement Splint (MAS) |
| ≥ 30 | Severe OSA | Urgent sleep physician consultation & PSG |
Traditional fingertip clip sensors frequently cause finger numbness and dislodge during sleep turns. The Berry BM2000A features an ergonomic medical-grade silicone ring probe designed for 8+ hours of continuous overnight recording, Bluetooth BLE sync, and automated clinical ODI reporting.
Request evaluation samples of BM2000A, iOS/Android BLE SDKs, and wholesale clinical pricing directly from the manufacturer.
Contact Australian Clinical Engineering Team